Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Telzuit Technologies, Inc. acquisition, securities offering complete
June 6th, 2005
Telzuit Technologies, Inc. d/b/a BioPatch Systems, and Taylor Madison Corp. (TMDN) announced that they have closed a definitive share exchange agreement providing for the acquisition by Taylor Madison Corp. of all of the issued and outstanding shares of Telzuit for an aggregate of 2,207,723 Series B Preferred shares of Taylor Madison. In connection with the transaction, Taylor Madison will soon change its name to "Telzuit Medical Technologies, Inc." Upon completion of the acquisition of Telzuit, Donald Sproat was elected president, chief executive officer, and chief financial officer and was named as a director of Taylor Madison, James Tolan was...
Source: Biotech Business Week (2005-06-06)
|
